925 followers
New article: LY294002 Is a Promising Inhibitor to Overcome Sorafenib Resistance in FLT3-ITD Mutant AML Cells by Interfering With PI3K/Akt Signaling Pathway https://t.co/6jGCBGqHIm #AML #leusm #hematology https://t.co/n3NFtJFlhS
New article: LY294002 Is a Promising Inhibitor to Overcome Sorafenib Resistance in FLT3-ITD Mutant AML Cells by Interfering With PI3K/Akt Signaling Pathway https://t.co/6jGCBGqHIm #AML #leusm #hematology https://t.co/n3NFtJFlhS
New research: LY294002 Is a Promising Inhibitor to Overcome Sorafenib Resistance in FLT3-ITD Mutant AML Cells by Interfering With PI3K/Akt Signaling Pathway: Internal tandem duplications (ITD) mutation within FMS-like tyrosine kinase 3 (FLT3),… https://t.c